Abstract |
Inhibition of histone deacetylase (HDAC) activity induces growth arrest, differentiation, and, in certain cell types, apoptosis. FR901228, FK228, or depsipeptide, is an HDAC inhibitor effective in T-cell lymphomas. Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) and remains incurable. We examined whether FR901228 is effective for treatment of ATL by assessing its ability to induce apoptosis of HTLV-1-infected T-cell lines and primary leukemic cells from ATL patients. FR901228 induced apoptosis of Tax-expressing and -unexpressing HTLV-1-infected T-cell lines and selective apoptosis of primary ATL cells, especially those of patients with acute ATL. FR901228 also efficiently reduced the DNA binding of NF-kappaB and AP-1 in HTLV-1-infected T-cell lines and primary ATL cells and down-regulated the expression of Bcl-x(L) and cyclin D2, regulated by NF-kappaB. Although the viral protein Tax is an activator of NF-kappaB and AP-1, FR901228-induced apoptosis was not associated with reduced expression of Tax. In vivo use of FR901228 partly inhibited the growth of tumors of HTLV-1-infected T cells transplanted subcutaneously in SCID mice. Our results indicated that FR901228 could induce apoptosis of these cells and suppress the expression of NF-kappaB and AP-1 and suggest that FR901228 could be therapeutically effective in ATL.
|
Authors | Naoki Mori, Takehiro Matsuda, Masayuki Tadano, Takao Kinjo, Yasuaki Yamada, Kunihiro Tsukasaki, Shuichi Ikeda, Yoshihiro Yamasaki, Yuetsu Tanaka, Takao Ohta, Teruo Iwamasa, Masao Tomonaga, Naoki Yamamoto |
Journal | Journal of virology
(J Virol)
Vol. 78
Issue 9
Pg. 4582-90
(May 2004)
ISSN: 0022-538X [Print] United States |
PMID | 15078940
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Retracted Publication)
|
Chemical References |
- Antibiotics, Antineoplastic
- Depsipeptides
- Histone Deacetylase Inhibitors
- NF-kappa B
- Peptides, Cyclic
- Transcription Factor AP-1
- romidepsin
|
Topics |
- Adult
- Animals
- Antibiotics, Antineoplastic
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Cell Line, Transformed
- Depsipeptides
- Disease Models, Animal
- Down-Regulation
- Histone Deacetylase Inhibitors
- Human T-lymphotropic virus 1
(drug effects)
- Humans
- Leukemia, T-Cell
(drug therapy)
- Mice
- Mice, SCID
- NF-kappa B
(drug effects, metabolism)
- Peptides, Cyclic
(pharmacology, therapeutic use)
- T-Lymphocytes
(virology)
- Transcription Factor AP-1
(drug effects, metabolism)
- Tumor Cells, Cultured
|